About [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum
[2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum (PubChem CID 159027825) has the molecular formula C80H95N11O2PdPt3S2-4
and a molecular weight of 1998.50 g/mol. Its IUPAC name is [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum.
Analyze [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum?
The IUPAC name of [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum (CID 159027825) is [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum.
What is the SMILES notation for [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum?
The canonical SMILES for [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum is CC1(Cc2nc(-c3ccccc3[N-]c3ccccc3)cs2)CCCC1.Cc1nc(-c2cccc3c(C4(C)CCCCC4)c[n-]c23)cs1.Cc1nc(C(C)(C)c2nc(CCC3(C)CCCC3)c[n-]2)co1.Cc1nc(Oc2nc(C(C)C3(C)CCCC3)c[n-]2)cn1-c1ccccc1.[Pd].[Pt].[Pt].[Pt].
What is the InChIKey of [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum?
The InChIKey is BTQQMMDIXHAJOU-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N2S.C21H25N4O.C19H21N2S.C18H26N3O.Pd.3Pt/c1-22(13-7-8-14-22)15-21-24-20(16-25-21)18-11-5-6-12-19(18)23-17-9-3-2-4-10-17;1-15(21(3)11-7-8-12-21)18-13-22-20(24-18)26-19-14-25(16(2)23-19)17-9-5-4-6-10-17;1-13-21-17(12-22-13)15-8-6-7-14-16(11-20-18(14)15)19(2)9-4-3-5-10-19;1-13-20-15(12-22-13)17(2,3)16-19-11-14(21-16)7-10-18(4)8-5-6-9-18;;;;/h2-6,9-12,16H,7-8,13-15H2,1H3;4-6,9-10,13-15H,7-8,11-12H2,1-3H3;6-8,11-12H,3-5,9-10H2,1-2H3;11-12H,5-10H2,1-4H3;;;;/q4*-1;;;;.
What are the key properties of [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum?
[2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum has a molecular weight of 1998.50 g/mol, XLogP of 21.89, 17 rotatable bonds, 0 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[2-[(1-methylcyclopentyl)methyl]-1,3-thiazol-4-yl]phenyl]-phenylazanide;2-methyl-4-[3-(1-methylcyclohexyl)indol-1-id-7-yl]-1,3-thiazole;2-methyl-4-[4-[1-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]oxy-1-phenylimidazole;2-methyl-4-[2-[4-[2-(1-methylcyclopentyl)ethyl]imidazol-1-id-2-yl]propan-2-yl]-1,3-oxazole;palladium;platinum is sourced from PubChem (CID 159027825), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).